Publication:
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis.

dc.contributor.authorDevesa, Ana
dc.contributor.authorFuster, Valentin
dc.contributor.authorVazirani, Ravi
dc.contributor.authorGarcia-Lunar, Ines
dc.contributor.authorOliva, Belen
dc.contributor.authorEspana, Samuel
dc.contributor.authorMoreno-Arciniegas, Andrea
dc.contributor.authorSanz, Javier
dc.contributor.authorPerez-Herreras, Cristina
dc.contributor.authorBueno, Hector
dc.contributor.authorLara-Pezzi, Enrique
dc.contributor.authorGarcia-Alvarez, Ana
dc.contributor.authorde Vega, Vicente Martínez
dc.contributor.authorFernandez-Friera, Leticia
dc.contributor.authorTrivieri, Maria G
dc.contributor.authorFernandez-Ortiz, Antonio
dc.contributor.authorRossello, Xavier
dc.contributor.authorSanchez-Gonzalez, Javier
dc.contributor.authorIbáñez, Borja
dc.contributor.funderCentro Nacional de Investigaciones Cardiovasculares Carlos III (España)es_ES
dc.contributor.funderBanco Santanderes_ES
dc.contributor.funderUnión Europea. Comisión Europeaes_ES
dc.contributor.funderMinisterio de Ciencia e Innovación (España)es_ES
dc.contributor.funderComunidad de Madrid (España)es_ES
dc.contributor.funderFundación La Caixaes_ES
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.contributor.funderFundación ProCNICes_ES
dc.contributor.funderMinisterio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España)es_ES
dc.date.accessioned2023-11-22T09:26:04Z
dc.date.available2023-11-22T09:26:04Z
dc.date.issued2023-11-01
dc.description.abstractOBJECTIVE Experimental evidence suggests that metabolic syndrome (MetS) is associated with changes in cardiac metabolism. Whether this association occurs in humans is unknown. RESEARCH DESIGN AND METHODS 821 asymptomatic individuals from the Progression of Early Subclinical Atherosclerosis (PESA) study (50.6 [46.9-53.6] years, 83.7% male) underwent two whole-body 18F-fluorodeoxyglucose positron emission tomography-magnetic resonance (18F-FDG PET-MR) 4.8 ± 0.6 years apart. Presence of myocardial 18F-FDG uptake was evaluated qualitatively and quantitatively. No myocardial uptake was grade 0, while positive uptake was classified in grades 1-3 according to target-to-background ratio tertiles. RESULTS One hundred fifty-six participants (19.0%) showed no myocardial 18F-FDG uptake, and this was significantly associated with higher prevalence of MetS (29.0% vs. 13.9%, P < 0.001), hypertension (29.0% vs. 18.0%, P = 0.002), and diabetes (11.0% vs. 3.2%, P < 0.001), and with higher insulin resistance index (HOMA-IR, 1.64% vs. 1.23%, P < 0.001). Absence of myocardial uptake was associated with higher prevalence of early atherosclerosis (i.e., arterial 18F-FDG uptake, P = 0.004). On follow-up, the associations between myocardial 18F-FDG uptake and risk factors were replicated, and MetS was more frequent in the group without myocardial uptake. The increase in HOMA-IR was associated with a progressive decrease in myocardial uptake (P < 0.001). In 82% of subjects, the categorization according to presence/absence of myocardial 18F-FDG uptake did not change between baseline and follow-up. MetS regression on follow-up was associated with a significant (P < 0.001) increase in myocardial uptake. CONCLUSIONS Apparently healthy individuals without cardiac 18F-FDG uptake have higher HOMA-IR and higher prevalence of MetS traits, cardiovascular risk factors, and early atherosclerosis. An improvement in cardiometabolic profile is associated with the recovery of myocardial 18F-FDG uptake at follow-up.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThe PESA study is funded by the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Santander Bank. B.I. is supported by the European Commission (grant numbers 819775 and 945118), by the Spanish Ministry of Science and Innovation (PID2019- 110369RB-I00), and by the Red Madrilena de ~ Nanomedicina en Imagen Molecular-Comunidad de Madrid (S2017/BMD-3867 RENIM-CM). A.D. is an Alfonso Martin Escudero fellow and is scientifically supported by La Caixa Foundation. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovacion (MCIN), and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/ 10.13039/501100011033).es_ES
dc.format.number11es_ES
dc.format.page2050es_ES
dc.format.volume46es_ES
dc.identifier.citationDiabetes Care. 2023 Nov 1;46(11):2050-2057.es_ES
dc.identifier.doi10.2337/dc23-0871es_ES
dc.identifier.e-issn1935-5548es_ES
dc.identifier.journalDiabetes carees_ES
dc.identifier.pubmedID37713581es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16709
dc.language.isoenges_ES
dc.publisherAmerican Diabetes Association (ADA)es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2019-110369RB-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/S2017/BMD-3867/RENIM-CMes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CEX2020-001041-Ses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/MICIN/AEI/10.13039/501100011033es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/819775es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/945118es_ES
dc.relation.publisherversion10.2337/dc23-0871es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Laboratorio Traslacional para la Imagen y Terapia Cardiovasculares_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshMetabolic Syndromees_ES
dc.subject.meshInsulin Resistancees_ES
dc.subject.meshAtherosclerosises_ES
dc.subject.meshMalees_ES
dc.subject.meshHumanses_ES
dc.subject.meshFemalees_ES
dc.subject.meshFluorodeoxyglucose F18es_ES
dc.subject.meshHeartes_ES
dc.subject.meshPositron-Emission Tomographyes_ES
dc.subject.meshRadiopharmaceuticalses_ES
dc.titleCardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication558474d4-85be-4127-bda8-59128f707249
relation.isAuthorOfPublicationde903570-4c8c-4bcb-8cfe-d077154694e0
relation.isAuthorOfPublication2cac2b58-fa25-494c-92c5-5ac91f3d2036
relation.isAuthorOfPublicationaa5c6326-5e02-4c53-afad-fdf9c0115861
relation.isAuthorOfPublication465de6aa-7383-4ba5-b278-765f894f2c87
relation.isAuthorOfPublication4e417023-fc1f-41d2-8130-485f76466465
relation.isAuthorOfPublicatione7d4df9b-2306-4955-ba22-17d066e07612
relation.isAuthorOfPublication92018446-2b00-4798-a27d-d2b26871b81b
relation.isAuthorOfPublication4b2a0672-e9a0-4788-b256-d3170c84aab2
relation.isAuthorOfPublicationc247543c-ab71-441c-8eec-b54f56c6a1ff
relation.isAuthorOfPublicationbbc835c4-284a-4845-8a6e-adf765b43cc1
relation.isAuthorOfPublicationb6428aa3-d242-4efb-a7a2-b977c3aeadd8
relation.isAuthorOfPublication2cac8bb6-2bff-4bf6-8209-bdbd21781786
relation.isAuthorOfPublication.latestForDiscovery558474d4-85be-4127-bda8-59128f707249

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Supplemental_material_Cardiac Insulin Resistance_Diabetes Care_2023.pdf
Size:
510.09 KB
Format:
Adobe Portable Document Format
Description:
Artículo
Loading...
Thumbnail Image
Name:
Cardiac Insulin Resistance_Diabetes Care_2023_1.pdf
Size:
19.47 MB
Format:
Adobe Portable Document Format
Description:
Artículo